Interestingly, serum from Nur77-null mice provoked a severe hypertrophy in cultured neonatal rat cardiomyocytes that was inhibited by the neuropeptide Y type I receptor antagonist BIBO3304, evidencing another promising mechanism through which Nur77 might be targeted in HF [18]. The gene discussed is NR4A1; the disease is hydrops fetalis.